Edition:
India

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

763.30INR
24 May 2019
Change (% chg)

Rs13.35 (+1.78%)
Prev Close
Rs749.95
Open
Rs747.00
Day's High
Rs766.15
Day's Low
Rs747.00
Volume
762,430
Avg. Vol
2,036,225
52-wk High
Rs986.10
52-wk Low
Rs719.80

Latest Key Developments (Source: Significant Developments)

Lupin Launches Budesonide Inhalation Suspension
Wednesday, 22 May 2019 

May 22 (Reuters) - Lupin Ltd ::SAYS LUPIN LAUNCHES BUDESONIDE INHALATION SUSPENSION.LUPIN LTD - DRUG INDICATED FOR THE MAINTENANCE TREATMENT OF ASTHMA AND AS PROPHYLACTIC THERAPY IN CHILDREN FROM 12 MONTHS TO 8 YEARS OF AGE.  Full Article

Lupin Says Hasn't Been Served Yet,Only Got Complaint In Lawsuit Against Pharma Cos In U.S.
Wednesday, 15 May 2019 

May 15 (Reuters) - Lupin Ltd ::SAYS HASN'T BEEN SERVED YET; HAS ONLY RECEIVED COMPLAINT IN LAWSUIT AGAINST PHARMA COS IN U.S..SAYS CONFIDENT OF DOUBLE DIGIT GROWTH IN INDIAN MARKET IN FY20.  Full Article

India's Lupin Posts March-Qtr Profit
Wednesday, 15 May 2019 

May 15 (Reuters) - Lupin Ltd ::MARCH QUARTER CONSOL NET PROFIT 2.90 BILLION RUPEES VERSUS LOSS OF 7.84 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR MARCH QUARTER CONSOL PROFIT WAS 4.18 BILLION RUPEES.MARCH QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 44.06 BILLION RUPEES VERSUS 40.34 BILLION RUPEES LAST YEAR.RECOMMENDED DIVIDEND OF 5 RUPEES PER SHARE.  Full Article

India's Lupin Gets EIR For Pharmacovigilance Inspection From U.S. FDA
Tuesday, 14 May 2019 

May 14 (Reuters) - Lupin Ltd ::GETS EIR FOR PHARMACOVIGILANCE INSPECTION FROM U.S. FDA.INSPECTION WAS CONDUCTED AT CO'S GLOBAL PHARMACOVIGILANCE GROUP DSRM.INSPECTION CLOSED WITH FOUR OBSERVATIONS.  Full Article

Lupin Launches Clobazam Tablets
Friday, 10 May 2019 

May 10 (Reuters) - Lupin Ltd ::LUPIN LAUNCHES CLOBAZAM TABLETS.  Full Article

Lupin In Alliance With Natco Pharma Gets FDA Approval For Bosentan Tablets
Tuesday, 30 Apr 2019 

April 30 (Reuters) - Lupin Ltd ::LUPIN IN ALLIANCE WITH NATCO RECEIVES FDA APPROVAL FOR BOSENTAN TABLETS.  Full Article

India's Lupin Gets FDA Approval For Testosterone Gel
Thursday, 11 Apr 2019 

April 11 (Reuters) - Lupin Ltd ::GETS FDA APPROVAL FOR TESTOSTERONE GEL.  Full Article

Lupin Launches Fluocinonide Ointment USP 0.05 Pct
Thursday, 28 Mar 2019 

March 28 (Reuters) - Lupin Ltd ::LUPIN LAUNCHES FLUOCINONIDE OINTMENT USP 0.05%.  Full Article

Lupin Gets USFDA Approval For Tadalafil Tablets Usp
Wednesday, 27 Mar 2019 

March 27 (Reuters) - Lupin Ltd ::GETS US FDA APPROVAL FOR TADALAFIL TABLETS USP.  Full Article

Lupin's Mammalian Facility Gets European Good Manufacturing Practice Certificate
Wednesday, 27 Mar 2019 

March 27 (Reuters) - Lupin Ltd ::GETS EUROPEAN GOOD MANUFACTURING PRACTICE CERTIFICATE FOR ITS MAMMALIAN FACILITY IN PUNE.ETANERCEPT BIOSIMILAR IS INTENDED TO BE MANUFACTURED IN MAMMALIAN FACILITY IN PUNE.  Full Article

BUZZ-India's Lupin falls close to 7-week low on Q4 profit miss

** Shares of Lupin Ltd fall as much as 5.9% to 736.40 rupees, touches a level close to 7-week low after the pharma co posted qtrly results below estimates